Richard Doll Seminars Archive: 2007 to 2010

Note: Details about the seminar programme have not been updated and may be incomplete

Programme for academic year 2009 to 2010

Michaelmas 2009 (Oct to Dec)

• 13 Oct   Dr Andrew Roddam, AMGEN, Uxbridge: The role of epidemiology in drug development: an inside perspective
• 20 Oct    Professor Betty Kirkwood, London School of Hygiene and Tropical Medicine: Meeting the millennium development goals for maternal and child survival: Does vitamin A supplementation of women of reproductive age have a role to play? Findings of the “OBAAPAVITA” trial, Ghana
• 27 Oct    Dr Kate Venables and Dr Lucy Carpenter, Porton Down: Mortality and cancer in Porton Down veterans
• 3 Nov     Professor Kay-Tee Khaw, University of Cambridge: Age and genes: modifiable risk factors?
• 10 Nov    Professor Valerie Beral, Dr Jane Green, and Dr Gillian Reeves, Cancer Epidemiology Unit, University of Oxford: Recent results from the Million Women Study
• 17 Nov    Professor Nicholas Christakis, Professor of Medical Sociology, Department of Health Care Policy, Harvard Medical School: Genetic basis for Social Network Structure and Social Aspects of Social Network Function
• 24 Nov    Dr Colin Baigent, CTSU, University of Oxford: Aspirin in the primary and secondary prevention of vascular disease
• 1 Dec      Professor Mike Kelly, The National Institute for Health and Care Excellence: Developing evidence based guidance for disease prevention and health improvement: the experience of NICE 2005-2009

Hilary 2010 (jan to mar)

• 19 Jan    Dr Marion Knight, NPEU, University of Oxford: Obesity in pregnancy; how BIG a problem is it?
• 26 Jan     Professor Eve Roman, University of York: Understanding the epidemiology of haematological malignancies
• 2 Feb      Professor Sally Lamb, University of Oxford/Warwick: Large simple trials of complex interventions: issues for design, analysis and conduct
• 9 Feb      Dr Chris Spencer, Department of Statistics, University of Oxford: Things to do with GWAS: Wellcome Trust Case Control Consortium 2
• 16 Feb    Professor Anthony Kessel, Health Protection Agency: The Swine Flu Epidemic: A perspective from the Health Protection Agency
• 23 Feb    Professor Diana Kuh, MRC Unit for Lifelong Health and Ageing: The MRC National Survey of Health and Development: looking back, looking forwards
• 2 Mar      Professor Julietta Patnick, NHS cancer screening programmes, Sheffield: Issues of Balance in Cancer Screening
• 9 Mar       Professor Mike Hawkins, BCCS - Birmingham: Consequences of Cancer Treatment when Young

Trinity 2010 (Apr to Jun)

• 27 Apr    Dr Gary Whitlock, CTSU, University of Oxford: Body mass index and mortality in 900 000 people: the Prospective Studies Collaboration
• 4 May     Dr Elizabeth Pisani, Dublin/London: Public Health Prostitution: how money and ideology have distorted the response to HIV
• 11 May    Professor John Geddes, University of Oxford: Long term therapy for bipolar disorder: implications of BALANCE
• 12 May (additional seminar)    Professor Andrew Morris, University of Dundee: Gearing an Entire Country for Diabetes Research: A View from the North
• 18 May    Professor Danny Dorling, University of Sheffield: Worldmapping: how and where do 57 million people a year die
• 25 May    NO SEMINAR
• 1 Jun       Dr Ruth Loos, University of Cambridge: The genetic epidemiology of common obesity – recent progress and future challenges
• 8 Jun      Professor Mark McCarthy, University of Oxford: Thinking big: large-scale genetic discovery for diabetes and obesity, biological inference and clinical relevance
• 15 Jun     Professor Ian Roberts, London School of Hygiene and Tropical Medicine: CANCELLED
• 6 Jul       Dr Evan Harris

************************************************************************************

Programme for academic year 2008 to 2009

Michaelmas 2008 (Oct to Dec)

• 14 Oct   Professor Ted Karpf, World Health Organization, Office of the Representative for Partnerships and UN Reform: Restoring Hope: Decent Care for all
• 21 Oct    Professor Tim Key, Cancer Epidemiology Unit, University of Oxford: Hormones and prostate cancer: results from EPIC
• 28 Oct    Professor Robert Snow, Malaria Public health and Epidemiology Group, KEMRI University of Oxford: Malaria burden worldwide: prospects for control or elimination?
• 4 Nov      Professor Roger Corder, William Harvey Research Institute, QMUL, London: The influence of dietary flavonoids on cardiovascular risk: studies of apples, berries, cocoa and red wine
• 11 Nov    NO SEMINAR
• 18 Nov    Professor Oliver James, Faculty of Medical Sciences, University of Newcastle, Newcastle-upon-Tyne: Worldwide Epidemiology of Primary Biliary Disease – A Model Autoimmune Disease?
• 25 Nov    Professor Chris Wild, Leeds Institute of Genetics, Health and Therapeutics: Mycotoxins – contamination of twenty-five percent of the world’s food supply but at what cost to human health?
• 2 Dec     Professor Arne Astrup, Head, Section of Diabetes and Obesity, University of Copenhagen, Denmark: The role of diet composition for body weight regulation: the role of specific nutrients

Hilary 2009 (jan to mar)

• 13 Jan    Professor Alastair Gray, Health Economics Unit, University of Oxford: The cost-effectiveness of policies to reduce radon-induced lung cancer
• 20 Jan     Professor Sir David Weatherall, Emeritus Regius Professor of Medicine, University of Oxford: Oxford’s contribution to global health
• 27 Jan     Professor Naveed Sattar, BHF Glasgow Cardiovascular Centre: Biomarkers in metabolic and vascular research: why, when and how?
• 3 Feb      Professor Michel Coleman, CRUK Cancer Survival Group, London School of Hygiene and Tropical Medicine: The CONCORD study: an international study of cancer survival
• 10 Feb    Professor Phil Kalra, Hope Hopsital, Salford Royal Hospitals Trust and the University of Manchester: Renovascular disease – insights from the ASTRAL trial
• 17 Feb    Professor Margaret Stanley, Department of Pathology, University of Cambridge: HPV vaccines – the end of cervical cancer?
• 24 Feb    Dr Richard Horton, Editor of The Lancet: Journals and society: science, policy, and the death and rebirth of The Lancet
• 3 Mar      Professor Raj Bhopal, Division of Community Health Sciences, Medical School, The University of Edinburgh: Retrospective cohort studies to fill the ethnicity and health information gap
• 10 Mar      Dr Helen McShane, The Jenner Institute, University of Oxford: Developing a new vaccine against TB – boosting BCG with MVA85A
• 17 Mar       Professor George Davey Smith, Department of Social Medicine, University of Bristol: Epidemiology and the ‘gloomy prospect’ – should we try and understand individual-level risk?

Trinity 2009 (Apr to Jun)

• 21 Apr    Lord Patten of Barnes, Chancellor of the University of Oxford: Politics and Public health in the 21^st century
• 28 Apr     Conrad Keating, CTSU, University of Oxford: Richard Doll
• 5 May       Professor Nicholas Wald, QMUL: The Polypill – a new approach to the prevention of cardiovascular disease
• 12 May    Professor Zhengming Chen, CTSU, University of Oxford: Kadoorie and other large scale epidemiological studies in China
• 19 May    Professor Nick J Wareham, Department of Public Health and Primary Care, University of Cambridge: Investigating the causes and prevention of type 2 diabetes
• 26 May    Professor Nick White, University of Oxford: Can malaria be eradicated?
• 2 Jun       Professor Julian Peto, London School of Hygiene and Tropical Medicine: Why the UK mesothelioma rate is the highest worldwide?
• 9 Jun       Professor Hugh Watkins, Department of Cardiovascular Medicine, University of Oxford: Complex cardiovascular phenotypes: advances in molecular genetics
• 16 Jun     Professor John Bell: Regius Professor of Medicine, University of Oxford: The future of Oxford’s contribution to public health and medicine

************************************************************************************

Programme for academic year 2007 to 2008

Michaelmas 2007 (Oct to Dec)

• 9 Oct   Professor Monique Breteler, Erasmus MC, University Medical Center, Rotterdam: Unravelling the causes of dementia: An epidemiologic approach
• 9 Oct     Dr Dorothy Mackerras, Public Health Nutrition, Food Standards Australia and New Zealand (FSANZ): The Aboriginal Birth Cohort Study
• 16 Oct    Professor Richard Wilkinson, School of Community Health Sciences, University of Nottingham: Dysfunctional societies: why even small differences in inequality matter?
• 23 Oct    Professor Malcolm Sim, Monash University, Melbourne, Australia: Post-deployment syndromes in war veterans: fact or fiction?
• 30 Oct    Professor Mary Dixon-Woods, Department of Health Science, University of Leicester: What’s wrong with the regulation of medical research?
• 6 Nov     Professor Sir Richard Peto, CTSU, University of Oxford: Cancer attributable and not attributable to smoking
• 13 Nov    Dr Mike Stroud, Institute of Human Nutrition, University of Southampton: Malnutrition in our midst – starvation in UK healthcare
• 20 Nov    Professor Sarah Darby, CTSU, University of Oxford: Radon and long cancer: your place or mine?
• 27 Nov    Professor Rory Hulman, DTU, University of Oxford: Can meta-analysis trump clinical trials? The rosiglitazone experience

Hilary 2008 (jan to mar)

NOTE: No information

Trinity 2008 (Apr to Jun)

• 22 Apr    Professor Miranda Mugford, Health Economics Group, Faculty of Health, University of East Anglia: How can economics be part of the ‘evidence base’ in health and social care?
• 29 Apr     Dr Peymane Adab, Deparment of Public Health and Epidemiology, University of Birmingham: Childhood obesity prevention: where do we start?
• 6 May      Professor Rochelle Walensky, General medicine and Infectious Disease at Massachusetts General Hospital, and Division of Infectious Diseases at Brigham and Women’s Hospital, Boston, USA: HIV Care in the United States and Africa: From Cohorts and Trials to Policy
• 13 May    Professor Debbie Lawlor, Department of Social Medicine, University of Bristol: Using genetic variants as instrumental variables to provide causal inference: Pot of gold or emperor’s new clothing?
• 20 May    Professor David Forman, University of Leeds and Yorkshire and northern Region Cancer Registry: Uses of routine data to improve cancer outcomes
• 27 May    Professor Adrian Hill, Jenner Vaccine Institute and Wellcome Trust Centre for Human Genetics: Progress in malaria vaccine development
• 3 Jun        Professor Harry Hemingway, Department of Epidemiology and Public Health, University College London: Understanding the aetiology and prognosis of angina pectoris phenotypes: insights from large scale studies
• 10 Jun     Professor David Hendry, Oxford Faculty of Economics: Automatic model selection approach
• 17 Jun     Dr Jim Otvos: What LDL and HDL Cholesterol Don’t Tell Us About LDL and HDL. Clinical Implications of Lipoprotein Particle Analysis by NMR Spectroscopy

************************************************************************************

Programme for Trinity 2007

trinity 2007 (apr to jun)

• 24 Apr    Dr Jose Villar, WHO and Department of Obstetrics and Gynaecology, University of Oxford: Cluster and individual level data to evaluate medical practice: caesarean delivery and perinatal outcomes
• 1 May      Professor Lesley Fallowfield, University of Sussex: Results from clinical trials: why we need patient reported outcomes
•  8 May     Professor David Simpson, Director, International Agency on Tobacco and Health: International Agency on Tobacco and Health – the future of international tobacco control
• 15 May    Professor Nigel Unwin, School of Population Health Sciences:
• 22 May    Dr Boby Mihaylova and Professor Alastair Gray: Heart Protection Study economic analyses
• 29 May    Jon Ayers, University of Aberdeen: Environmental influences and asthma
• 5 Jun        Dr Rafael Perera and Professor Paul Glasziou: NT-proBNP
• 12 Jun      Dr Ian White, MRC Biostatistics Unit, University of Cambridge: Clinical Value of Predictive Models